Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice
Yoshiaki Kubota, … , Colin L. Stewart, Toshio Suda
Yoshiaki Kubota, … , Colin L. Stewart, Toshio Suda
Published June 2, 2008
Citation Information: J Clin Invest. 2008;118(7):2393-2403. https://doi.org/10.1172/JCI34882.
View: Text | PDF
Research Article Vascular biology

Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice

  • Text
  • PDF
Abstract

To meet tissue requirements for oxygen, capillaries must be properly distributed without excess or shortage. In this process, tissue oxygen concentration is well known to determine capillary density via the hypoxia-induced cascade, in which HIFs and VEGF play key roles. However, some additional mechanisms modulating this cascade are suggested to be involved in precise capillary network formation. Here, we showed that leukemia inhibitory factor (LIF) was predominantly expressed in developing endothelium, while its receptor was expressed in surrounding cells such as retinal astrocytes. The retinas of Lif–/– mice displayed increased microvessel density accompanied by sustained tip cell activity, due to increased VEGF expression by astrocytes in the vascularized area. Lif–/– mice resisted hyperoxygen insult in the oxygen-induced retinopathy model, whereas they paradoxically had increased numbers of neovascular tufts. In an in vitro study, LIF inhibited hypoxia-induced VEGF expression and proliferation in cultured astrocytes. Lif–/– mice also exhibited similarly increased microvessel density and upregulated VEGF in various tissues outside the retina. Together, these findings suggest that tissues and advancing vasculature communicate to ensure adequate vascularization using LIF as well as oxygen, which suggests a new strategy for antiangiogenic therapy in human diseases such as diabetic retinopathy and cancer.

Authors

Yoshiaki Kubota, Masanori Hirashima, Kazuo Kishi, Colin L. Stewart, Toshio Suda

×

Figure 4

Increased VEGF expression in the vascularized area of Lif–/– retina.

Options: View larger image (or click on image) Download as PowerPoint
Increased VEGF expression in the vascularized area of Lif–/– retina.
   ...
(A–F) ISH for VEGF combined with IHC for collagen IV. Note the increase of VEGF-expressing cells in Lif–/– mice in the vascularized area. Boxed regions in B and E are shown at higher magnification in C and F as indicated. Dotted lines in A, B, D, and E indicate the sprouting edges. (G–J) Triple IHC for PDGFRα, PECAM-1, and HIF-1α (G and I) or for PDGFRα, HIF-1α, and DAPI (H and J) in P4 retinas of Lif+/+ and Lif–/– mice. Note the increased number of astrocytes with HIF-1α (arrows) and nuclear translocated HIF-1α proteins (arrowheads) in the vascularized area of Lif–/– retinas. (K) Quantitative RT-PCR of vegfa with isolated RNA from various retinal stages (n = 5 per group). (L) Quantification of astrocytes with HIF-1α in the vascularized area (average numbers from 8 random FOV in the vascularized area per retina; n = 6). (M) Quantitative PCR of hif-1α for isolated RNA from P4 retina (n = 5). (N–S) ISH for VEGF combined with isolectin staining in P4 trachea of Lif+/+ and Lif–/– mice. Note the increase in VEGF-expressing mucosal epithelial cells in Lif–/– mice, especially in the vascularized area. Dotted lines flank a cartilaginous ring area. (T–Y) Double IHC of PECAM-1 and VEGF on E11 embryos. (Z and AA) Quantitative PCR of vegfa for isolated RNA from P4 trachea (Z) or E11 embryos (AA) (n = 5 per group). Scale bars: 50 μm. *P < 0.03 versus Lif+/+.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts